About Thomas Kluz
Form D filings for Novastream Therapeutics in 2023 list Thomas Kluz as director.
Thomas Kluz first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Kluz in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Kluz works with at each company, as listed on that company's latest Form D.
Novastream Therapeutics Inc. · Form D, Oct 17, 2023